LETFIT 2.5 MG

Non-steroidal aromatase inhibitor that significantly reduces estrogen production and is used in hormone-sensitive breast cancer.

Letfit 2.5 mg is a brand name for oral letrozole. It is a non-steroidal aromatase inhibitor primarily prescribed for postmenopausal women with hormone-sensitive conditions.

Primary Uses & Indications

1. Hormone Receptor-Positive Breast Cancer: Used as a primary or secondary (adjuvant) treatment in postmenopausal women to reduce the risk of cancer recurrence or manage advanced stage progression.
2. Off-Label Ovulation Induction: Frequently prescribed by fertility specialists off-label to induce ovulation in women with polycystic ovary syndrome (PCOS) or unexplained infertility.